Role of CD97stalk and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients

被引：11

作者：

Liu Yong

Chen Li

Peng Shu-you

Chen Zhou-xun

C Hoang-Vu

机构：

[1] Yangzhou University,Department of Surgery, Second Affiliated Hospital, School of Medicine

[2] Zhejiang University,Department of Surgery, Second Affiliated Hospital, School of Medicine

[3] University of Halle-Wittenberg,Department of Surgery

来源：

Journal of Zhejiang University Science B | 2005年 / 6卷 / 9期

关键词：

CD97; CD55; Gastric carcinoma; Molecular markers; A; R735.2;

D O I：

10.1007/BF02841003

中图分类号：

学科分类号：

摘要：

Objectives: To explore the mechanism of development and aggressiveness in gastric carcinomas by investigating the expression and role of CD97 and its cellular ligand CD55 in gastric carcinomas. Methods: Tumor and corresponding normal mucosal tissue, collected from 39 gastric carcinoma patients, were examined by immunohistochemistry and RT-PCR for the expression of CD97 and CD55. Results: CD97stalk was strongly stained on scattered tumor cells or small tumor cell clusters at the invasion front of gastric carcinomas. The expression of CD97stalk was frequently observed in tumors of stage I and T1 gastric carcinoma patients. The expression of CD97stalk between Stage I and Stage II, III, IV specimens showed significant difference (P<0.05), between T1 and T2, T3, T4 specimens also showed significant difference (P<0.05). Specimens with tumor invasion depth limited in mucosa of T1 specimens showed higher positive CD55 expression than specimens with the same tumor invasion depth in T2, T3, T4 specimens, the expression of CD55 between T1 and T2 T3, T4 specimens was significantly different (P<0.05). There was strong correlation between the distribution patterns of CD97stalk and CD55 on tumor tissues (r=0.73,P<0.05). Signet ring cell carcinomas frequently contained strong CD97stalk and CD55-staining. Conclusions: Our results suggest that CD97stalk is probably involved in the growth, invasion and aggressiveness of gastric carcinomas by binding its cellular ligand CD55. CD97stalk and CD55 could be useful as molecular markers for prognosis and therapy of gastric carcinoma patients.

引用

页码：913 / 918

页数：5

共 115 条

[1]

Aust G.(1997)CD97: A dedifferentiation marker in human thyroid carcinomas Cancer Res. 57 1798-1806

[2]

Eichler W.(2002)CD97, but not its closely related EGF-TM7 family member EMR2, is expressed on gastric, pancreatic, and esophageal carcinomas Am. J. Clin. Pathol. 118 699-707

[3]

Laue S.(2002)CD97, CD95 and Fas-L clearly discriminate between chronic pancreatitis and pancreatic ductal adenocarcinoma in perioperative evaluation of cryocut sections Pathol Int. 52 83-88

[4]

Lehmann I.(1998)Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front Pathol. Res. Pract. 194 701-704

[5]

Heldin N.E.(2001)Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment Proc. Natl. Acad. Sci. USA 98 10356-10361

[6]

Lotz O.(1996)The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF) J. Exp. Med. 184 1185-1189

[7]

Scherbaum W.A.(1999)Regulation of CD97 protein in thyroid carcinoma Clin. Endocrinol. Metab. 84 1104-1109

[8]

Dralle H.(2001)Tissue distribution of the human CD97 EGF-TM7 receptor Tissue Antigens 57 325-331

[9]

Hoang-Vu C.(2004)The human EGF-TM7 family: A postgenomic view Immunogenetics 55 655-666

[10]

Aust G.(2001)CD55 is over-expressed in the tumour environment Br. J. Cancer 84 80-86

← 1 2 3 4 5 6 7 8 9 10 →